Loading…
Induction of Fas Ligand-Mediated Apoptosis by Interferon-α
Interferon-α (IFN-α) was among the first cytokines studied and the earliest to be used in clinical medicine for the treatment of viral infections and malignancies. Although the capacity of IFN-α to augment NK cell cytotoxicity against virus-infected target cells or tumor cells is well established, t...
Saved in:
Published in: | Clinical immunology (Orlando, Fla.) Fla.), 2000-06, Vol.95 (3), p.218-226 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Interferon-α (IFN-α) was among the first cytokines studied and the earliest to be used in clinical medicine for the treatment of viral infections and malignancies. Although the capacity of IFN-α to augment NK cell cytotoxicity against virus-infected target cells or tumor cells is well established, the mechanism has not been fully elucidated. Here we report that IFN-α stimulation of PBMC from healthy donors induces Fas (CD95) ligand (FasL) transcription and leads to increased cell surface FasL expression exclusively on the NK cell fraction. Furthermore, IFN-α augments the FasL-mediated cytotoxicity of normal PBMC against Fas-sensitive lymphoid tumor cells. In the context of innate immunity, induction of FasL by IFN-α can be viewed as an efficient mechanism to potentiate NK cell cytotoxicity in the presence of harmful targets, such as virally infected or transformed cells. |
---|---|
ISSN: | 1521-6616 1521-7035 |
DOI: | 10.1006/clim.2000.4866 |